Clinical trials: Normal Cognition
Alzheimer's Disease, Mild Cognitive Impairment
Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)
The primary objective of this protocol is to determine if brain amyloid imaged with florbetapir F 18 (18F-AV-45) PET scans is predictive of progressive cognitive impairment during the subsequent 36 months for groups of: normal…
- Trial name
- NCT00857506
- Testing
- florbetapir F 18
- Where
- 8 sites in United States
- Volunteers
- 152 people
- Sponsor
- Avid Radiopharmaceuticals
Healthy
Cognitive Stimulation Study
This study will evaluate the influence of non-invasive brain stimulation on different elements of cognitive function in healthy persons between the ages of 18-90 years.
- Trial name
- CogStim (NCT02067689)
- Testing
- Transcranial Direct Current Stimulation
- Where
- United States
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- University of Florida
Diabetes
Neuropsychiatric Factors
It is estimated that approximately 20-25% of diabetic patients will have at least one trophic disorder during their period. The appearance of a trophic disorder in a diabetic patient is a serious complication, indicating that…
- Trial name
- Diapepsy (NCT03323281)
- Testing
- Neuropsychological assessments
- Where
- France
- Volunteers
- 266 people
- Sponsor
- University Hospital, Montpellier
Breast Cancer, Cognitive Impairment
Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment
The aim of this study is to investigate whether a high definition tDCS-accompanied intensive cognitive training of working memory leads to performance improvement in women with post-chemotherapy cognitive impairment after breast…
- Trial name
- NeuroMod-PCCI (NCT04817566)
- Testing
- Anodal tDCS, Intensive cognitive training
- Where
- Germany
- Volunteers
- 52 people
- Sponsor
- University Medicine Greifswald
Breast Cancer, Sarcoma
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
This is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived neuropathic factor (BDNF) levels in cancer survivors (recently…
- Conditions
- Breast Cancer, Sarcoma, Gastric Cancer, Lung Cancer
- Trial name
- NCT06580002
- Testing
- Riluzole
- Where
- United States
- Volunteers
- 75 people
- Sponsor
- University of California, Irvine
Breast Cancer
Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors
The purpose of this study is to evaluate MBSR(BC), an intensive meditation-based stress reduction intervention, in order to determine its efficacy in improving cognitive functioning among breast cancer survivors.
- Trial name
- NCT02786797
- Testing
- MBSR(BC) 6 Week Program, BCES 6 Week Program
- Where
- 5 sites in United States
- Volunteers
- 214 people
- Sponsor
- University of South Florida
Breast Cancer, Long-Term Survivors
Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
The purpose of this study is to learn more about how chemotherapy affects an individual's thinking abilities (cognition). Some research has shown that chemotherapy can cause changes in cognition in breast cancer survivors.
- Trial name
- NCT00496613
- Testing
- Mini-Mental State Exam and Blood draw
- Where
- 3 sites in United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Memorial Sloan Kettering Cancer Center